Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-3 Shelf registration
- 4.1 Subscription Rights Certificate
- 5.1 Opinion of Baker & Hostetler LLP
- 10.1 Collaboration and License Agreement
- 23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
- 107 Exhibit 107
Associated filings
- 7 Feb 23 424B4 Prospectus supplement with pricing info
- 6 Feb 23 EFFECT Notice of effectiveness
- 20 Jan 23 S-3/A Shelf registration (amended)
-
21 Dec 22 S-3 Shelf registration
SMMT similar filings
Filing view
External links
SUMMIT THERAPEUTICS INC. FORM S-3
EX-23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Summit Therapeutics Inc. of our report dated March 31, 2021 relating to the financial statements, which appears in Summit Therapeutics Inc.'s Form 10-K/A for the year ended December 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/PricewaterhouseCoopers LLP
Reading, United Kingdom
December 21, 2022
1